SUSTAINED EFFICACY AND SAFETY OF BIMEKIZUMAB IN PATIENTS WITH ACTIVE PSORIATIC ARTHRITIS AND PRIOR INADEQUATE RESPONSE TO TUMOUR NECROSIS FACTOR INHIBITORS: RESULTS FROM THE PHASE 3 BE COMPLETE STUDY AND ITS OPEN-LABEL EXTENSION UP TO 1 YEAR.
| Autor: | Coates, L., Landewé, R. B. M., Mcinnes, I., Mease, P. J., Ritchlin, C. T., Tanaka, Y., Asahina, A., Behrens, F., Gladman, D. D., Gossec, L., Gottlieb, A. B., Warren, R. B., Ink, B., Bajracharya, R., Coarse, J., Merola, J. F. |
|---|---|
| Zdroj: | Annals of the Rheumatic Diseases; 2023 Supplement, Vol. 82, p346-347, 2p |
| Databáze: | Complementary Index |
| Externí odkaz: |
|